Nomura Holdings, Inc.
NYSE:NMRFinancial - Capital Markets
-$0.12 today
- Market cap
- $27.29B
- Beta
- 0.61
- P/E (TTM)
- 0.3
- EPS (TTM)
- $4,986.67
- Dividend yield
- 3.55%
Volume 3.51M
Average 1.75M
NMR EBITDA Margin
EBITDA as a percentage of revenue.
Nomura Holdings, Inc.NYSE: NMR
EBITDA Margin · Q1 FY2027 · quarter ended Jun 2026
EBITDA Margin widens to 30.8%
EBITDA Margin was 30.8% in Q1 FY2027, up 16.4 pp from a year earlier. On a trailing-twelve-month basis it was 14.1%, up 2.2 pp year over year. Over 3 fiscal years it widened by 3.6 pp.
Context
- EBITDA Margin widened in 2 of the last 3 fiscal years.
- FY2026 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 2 analysts of 33.7% for the fiscal year ending Mar 2027, up from 12.8% in FY2026.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- 30.8%+21.5 pp QoQ
- Last fiscal yearMar 2026
- 12.8%+0.9 pp YoY
- LTMJun 2026
- 14.1%+2.2 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +16.4 pp | — | — |
| 1 year | +0.9 pp | +20.9 pp | +20.0 pp |
| 3 years | +3.6 pp | +22.4 pp | +18.8 pp |
| 5 years | +27.8 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2026
- 12.8%
- Year-over-year change
- +0.9pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 12.8% | +0.9pp |
| FY2025 | 2025-03-31 | 11.8% | +3.4pp |
| FY2024 | 2024-03-31 | 8.4% | -0.7pp |
| FY2023 | 2023-03-31 | 9.2% | -11.6pp |
| FY2022 | 2022-03-31 | 20.8% | — |
EBITDA Margin vs competitors
How NMR compares with its peers on the latest reported figures
- NMR's LTM Jun 2026 EBITDA Margin of 14.1% is the 8th highest of the 9 companies compared; the peer median is 22.5%.
- Its year-over-year change of +2.2 pp is the 5th highest of 9, against a peer median of +1.5 pp.
- Over three fiscal years its change of +3.6 pp compares with a peer median of -5.8 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 29.3% | +14.4 pp | -5.7 pp | |
| LTM Jun 2026 | 27.8% | +13.0 pp | -12.9 pp | |
| LTM Sep 2026 | 26.7% | +8.3 pp | -4.0 pp | |
| LTM Sep 2026 | 22.9% | -0.6 pp | -5.8 pp | |
| LTM Jun 2026 | 22.2% | +3.5 pp | -5.6 pp | |
| LTM Aug 2026 | 18.8% | -16.2 pp | -23.9 pp | |
| LTM Mar 2026 | 15.4% | -0.9 pp | +9.9 pp | |
| LTM Jun 2026 | 14.1% | +2.2 pp | +3.6 pp | |
| LTM Sep 2026 | 10.6% | -4.8 pp | -10.7 pp | |
| Peer median (excluding NMR) | 22.5% | +1.5 pp | -5.8 pp | |
Competitors are the stored peer set for NMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 1.37T | 2.3T | 3.97T | 4.51T | 4.76T |
| Cost of Revenue | 230.11B | 1.15T | 2.6T | 2.84T | 2.59T |
| Gross Profit | 1.14T | 1.14T | 1.38T | 1.66T | 2.17T |
| Gross Margin | 83.3% | 49.9% | 34.7% | 36.9% | 45.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 529.51B | 605.79B | 673.52B | 732.39B | 1.37T |
| Operating Expenses | 917.09B | 995.5B | 1.1T | 1.19T | 1.63T |
| Depreciation & Amortization | 59.52B | 61.42B | 61.34B | 61.65B | 68.27B |
| EBITDA | 286.15B | 210.9B | 335.19B | 533.62B | 608.09B |
| EBITDA Margin | 20.8% | 9.2% | 8.4% | 11.8% | 12.8% |
| Operating Income | 226.62B | 149.47B | 273.85B | 471.96B | 539.82B |
| Operating Margin | 16.5% | 6.5% | 6.9% | 10.5% | 11.3% |
| Interest Income | 284.22B | 1.11T | 2.62T | 2.93T | 2.67T |
| Interest Expense | 230.11B | 1.15T | 2.6T | 2.84T | 2.59T |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 226.62B | 149.47B | 273.85B | 471.96B | 539.82B |
| Pre-Tax Margin | 16.5% | 6.5% | 6.9% | 10.5% | 11.3% |
| Income Tax Expense | 80.09B | 57.8B | 96.63B | 124.71B | 165.44B |
| Net Income | 143B | 92.79B | 165.86B | 340.74B | 362.13B |
| Net Margin | 10.4% | 4.0% | 4.2% | 7.6% | 7.6% |
| EPS (Basic) | 46.68 | 30.86 | 54.97 | 115.30 | 123.08 |
| EPS (Diluted) | 45.23 | 29.74 | 52.75 | 111.03 | 118.99 |
| Weighted Avg Shares | 3.06B | 3.01B | 3.02B | 2.96B | 2.94B |
| Weighted Avg Shares (Diluted) | 3.16B | 3.11B | 3.14B | 3.07B | 3.04B |
Nomura Holdings, Inc.
NYSE:NMR
Intrinsic Alpha fair value
Locked
Current Price
$9.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.